Literature DB >> 22296567

In-hospital outcomes and cost assessment between bipolar versus monopolar transurethral resection of the prostate.

Toru Sugihara1, Hideo Yasunaga, Hiromasa Horiguchi, Mitsuhiro Nakamura, Hiroaki Nishimatsu, Haruki Kume, Kazuhiko Ohe, Shinya Matsuda, Yukio Homma.   

Abstract

PURPOSE: We compared the in-hospital outcomes between bipolar and monopolar transurethral resection of the prostate (B-TURP and M-TURP, respectively) on a real-world practice using a large database. PATIENTS AND METHODS: Patients who underwent TURP were extracted from the Diagnosis Procedure Combination database, which is a case-mix administrative claims database in Japan. TURP procedures were classified into M-TURP and B-TURP groups according to intraoperative use or nonuse of D-sorbitol solution, respectively, which is the only nonelectrolyte bladder irrigation fluid for M-TURP available in Japan. To exclude causality among autologous and homologous transfusion events, we confined eligible hospitals to those in which no autologous blood preparation was undertaken for TURP and whose annual surgical caseloads were 15 cases or more. Multivariate analyses were conducted for homologous transfusion, postoperative complications, operative time, postoperative length of stay, and total costs.
RESULTS: There were 5155 M-TURP and 1531 B-TURP patients identified. The results for M-TURP vs B-TURP (effect sizes were evaluated with reference to M-TURP) were 2.3% vs 1.3% for transfusion (odds ratio [OR]=0.54; P=0.013), 3.3% vs 1.7% for postoperative complications (OR=0.46; P<0.01), 98 vs 116 minutes for operative time (20.5% increase; P<0.001), 8.65 vs 8.45 days for postoperative stay (3.6% reduction; P=0.003), and $6103 vs $6062 for cost (1.7% reduction; P=0.018).
CONCLUSION: B-TURP had significantly lower rates of transfusion and postoperative complications, but a longer operative time. The impacts of B-TURP on shortening the hospital stay and lowering the costs were of little clinical significance.

Entities:  

Mesh:

Year:  2012        PMID: 22296567      PMCID: PMC3412058          DOI: 10.1089/end.2011.0592

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  26 in total

1.  External validity of randomised controlled trials: "to whom do the results of this trial apply?".

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

2.  The hemostatic properties of transurethral plasmakinetic resection of the prostate: comparison with conventional resectoscope in an ex vivo study.

Authors:  Lijun Qu; Xinghuan Wang; Xing Huang; Yanqing Zhang; Xiao Zeng
Journal:  Urol Int       Date:  2008-05-14       Impact factor: 2.089

3.  [Bipolar versus monopolar transurethral resection of the prostate: peroperative analysis of the results].

Authors:  J M Abascal Junquera; L Cecchini Rosell; C Salvador Lacambra; R Martos Calvo; A Celma Domenech; J Morote Robles
Journal:  Actas Urol Esp       Date:  2006 Jul-Aug       Impact factor: 0.994

4.  Bipolar versus monopolar transurethral resection of prostate: randomized controlled study.

Authors:  Harbans Singh; Mahesh R Desai; Prajay Shrivastav; Kishor Vani
Journal:  J Endourol       Date:  2005-04       Impact factor: 2.942

5.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

Review 6.  Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials.

Authors:  Tania Lourenco; Robert Pickard; Luke Vale; Adrian Grant; Cynthia Fraser; Graeme MacLennan; James N'Dow
Journal:  BMJ       Date:  2008-06-30

7.  Bipolar versus monopolar transurethral resection of prostate: pathologic study in canines.

Authors:  Xing Huang; Xing-Huan Wang; Li-Jun Qu; Xiao-Yong Pu; Xiao Zeng
Journal:  Urology       Date:  2007-07       Impact factor: 2.649

8.  [Transurethral resection of bladder tumors and prostate enlargement in physiological saline solution (TURIS). A prospective study].

Authors:  A Rose; S Suttor; P J Goebell; R Rossi; H Rübben
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

9.  Bipolar transurethral resection in saline--an alternative surgical treatment for bladder outlet obstruction?

Authors:  Dirk P J Michielsen; Tibaut Debacker; Veerle De Boe; Caroline Van Lersberghe; Leonard Kaufman; Johan G Braeckman; Jean-Jacques Amy; Frans I Keuppens
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450

10.  A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system.

Authors:  Henry S S Ho; Sidney K H Yip; Kok B Lim; Stephanie Fook; Keong T Foo; Christopher W S Cheng
Journal:  Eur Urol       Date:  2007-03-28       Impact factor: 20.096

View more
  4 in total

1.  Post-transurethral resection of prostate urethral strictures: Are they often underreported? A single-center retrospective observational cohort study.

Authors:  Hariharasudhan Sekar; Velmurugan Palaniyandi; Sriram Krishnamoorthy; Natarajan Kumaresan
Journal:  Urol Ann       Date:  2021-10-12

Review 2.  A Cost-Benefit Analysis of Bipolar TURP for the Treatment of Bladder Outflow Obstruction.

Authors:  Giacomo Maria Pirola; Martina Maggi; Daniele Castellani; Alessandro Sciarra; Emanuele Rubilotta; Marilena Gubbiotti
Journal:  Res Rep Urol       Date:  2021-07-09

Review 3.  The TURis System for Transurethral Resection of the Prostate: A NICE Medical Technology Guidance.

Authors:  Andrew Cleves; Paul Dimmock; Neil Hewitt; Grace Carolan-Rees
Journal:  Appl Health Econ Health Policy       Date:  2016-06       Impact factor: 2.561

4.  Monopolar versus bipolar transurethral resection of prostate for benign prostatic hyperplasia: Operative outcomes and surgeon preferences, a real-world scenario.

Authors:  Vijay Kumar Sarma Madduri; Malay Kumar Bera; Dilip Kumar Pal
Journal:  Urol Ann       Date:  2016 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.